Skip to main content Skip to section navigation Skip to footer
Aethlon Medical, Inc. Corporate Home
  • The Hemopurifier®
    • Overview
    • The Hemopurifier® in Cancer
    • The Hemopurifier® in Infectious Disease
  • About
    • Overview
    • Leadership
    • Board of Directors
  • News & Media
    • Press Releases
    • Presentations
    • Events
    • Publications
    • Training Videos
  • Investors
    • Overview
    • Corporate News / Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
    • Analyst Coverage
  • Contact Us
Investors
  • Overview
  • Corporate News / Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Presentations
    • Leadership
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Overview
    • Quote
    • Charts
    • Historical Data
    • IRS Form 8937 for 2019 Reverse Stock Split
    • IRS Form 8937 for 2023 Reverse Stock Split
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Governance Documents
  • Analyst Coverage

Press Releases

  • Corporate News / Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Aug 11, 2020

Aethlon Medical Announces First Quarter Financial Results and Provides Corporate Update

Aug 6, 2020

Aethlon Medical Announces Collaboration with University of Pittsburgh on NIH Grant for Head and Neck Cancer

Aug 4, 2020

Aethlon Medical To Release First Quarter Financial Results and Host Conference Call on August 11, 2020

Jun 25, 2020

Aethlon Medical Announces Fiscal Year Financial Results and Provides Corporate Update

Jun 22, 2020

Aethlon Medical Presents Hemopurifier® Data at the American Association for Cancer Research 2020 Annual Meeting

Jun 18, 2020

Aethlon Announces FDA Approval of IDE Supplement for COVID-19 Patients

Jun 16, 2020

Aethlon Medical To Release Fourth Quarter Financial Results and Host Conference Call on June 25, 2020

Mar 24, 2020

Aethlon Announces Issuance of European Patent for the Hemopurifier® in Cancer

Feb 24, 2020

Securities and Exchange Commission (SEC) Order for Halt in trading of Aethlon Medical Stock Expires

Feb 10, 2020

Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • …
  • Page 26
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
Linkedin
Privacy Policy Disclaimer Sitemap Accessibility Statement
©2025 Aethlon Medical, Inc. All Rights Reserved.